Bayer Foe Blocked From Serving Docs Via Email Amid Virus
A California federal judge overseeing a $114 million antitrust case against U.S.-based Bayer HealthCare LLC ruled Tuesday that the COVID-19 pandemic isn't enough reason to allow the generic pet medication company...To view the full article, register now.
Already a subscriber? Click here to view full article